Every 424B that RECOVERY INC A (MSPR) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 424B covers the supplement that carries the terms of a priced offering, so if you follow MSPR and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full MSPR filings page.
MSP Recovery, Inc. files a prospectus supplement to register up to 909,982 shares of Class A Common Stock, up to 755,200,000 warrants to purchase Class A Common Stock, and up to 236,019 shares issuable upon exercise of warrants.
The supplement describes resale by selling securityholders of various share groups (Founder Shares, Private Units, Up-C exchangeable shares and other contract issuances) and discloses that cash proceeds to the company are expected to be nominal from the Public Warrants (less than $500) and that the company will not retain proceeds from the New Warrants. The filing also attaches a Form 8-K disclosing one-time advances: a $0.1 million discretionary Operational Collection Floor advance from Hazel Partners Holdings, LLC and a $0.1 million one-time advance of recovery proceeds from VRM MSP Recovery Partners, LLC; both advances are described as standalone, discretionary accommodations and do not create ongoing committed liquidity.
MSP Recovery, Inc. files a prospectus supplement registering 56,896 shares of Class A Common Stock for resale.
The supplement states the registered shares include 28,572 shares issuable upon exercise of VRM Warrants, 2,858 issued and 14,286 issuable to VRP, and 11,180 issued to Palantir. The VRM and VRP warrants have a $0.0175 exercise price, producing only nominal proceeds if exercised.
The filing also discloses two one-time advances: a $0.1 million advance from Hazel Partners (March 23, 2026) and a $0.1 million recovery-proceeds advance from VRM (March 20, 2026), each described as standalone accommodations with no commitment for further funding.
MSP Recovery, Inc. amends its prospectus to register up to 909,982 shares of Class A Common Stock, up to 755,200,000 New Warrants, and up to 236,019 shares issuable upon warrant exercises, for resale by selling securityholders.
The supplement discloses that Public Warrants (exercise price $0.4375) are likely to be exercised but would generate nominal proceeds, while New Warrants (exercise price $50,312.50) are unlikely to be exercised given the market price. The filing also reports two one-time advances—$0.2M from Hazel Partners and $0.2M from VRM—to provide short-term liquidity, and the resignations of a director and the CFO (February 2026).
MSP Recovery, Inc. files a prospectus supplement registering up to 32,220 shares of Class A common stock for resale by selling securityholders, including up to 15,239 shares issuable upon exercise of a CPIA Warrant.
The supplement attaches a Form 8-K describing two one-time advances of $0.2 million each from Hazel Partners Holdings, LLC and VRM MSP Recovery Partners, LLC to support operations and accounts payable, respectively, and states the Hazel advance is discretionary and does not reopen facility capacity. The filing discloses the resignation of director Ophir Sternberg and CFO Francisco Rivas-Vasquez, and notes a 1-for-7 reverse split effective September 1, 2025. Share and per-share figures in the supplement are adjusted for the reverse split.
MSP Recovery, Inc. is registering 285,715 shares of Class A Common Stock for resale by a selling securityholder under Prospectus Supplement No. 57.
The resale registration covers shares originally issued or issuable to YA II PN, Ltd. (Yorkville) under the Standby Equity Purchase Agreement (the Yorkville SEPA). The Yorkville SEPA contemplates purchases of up to $250 million of Class A Common Stock, but is subject to an Ownership Limitation of 9.99% and an Exchange Cap that was effectively lifted January 8, 2025. The prospectus supplement incorporates the Company’s Form 8-K disclosure, which also describes Yorkville Convertible Notes with aggregate advances and specified conversion pricing and a variety of amendments to pricing floors, maturities, and other terms.
MSP Recovery, Inc. files a prospectus supplement to register 56,896 shares of Class A common stock for resale by selling securityholders, including warrants and shares issued to Virage entities and Palantir, adjusted for a 1-for-7 reverse split.
The supplement attaches a Form 8-K that discloses two short-term one-time advances: a $0.2 million discretionary advance from Hazel Partners under the existing working capital facility and a $0.2 million one-time advance from VRM to support accounts payable, each described as non-recurring and not creating ongoing funding commitments. The 8-K also reports the immediate resignations of director Ophir Sternberg and CFO Francisco Rivas-Vasquez.
MSP Recovery, Inc. files a prospectus supplement covering the resale of up to 909,982 shares of Class A common stock and up to 755,200,000 warrants, plus the issuance of up to 236,019 shares upon warrant exercise. The supplement also attaches a new current report.
The report describes a $250,000 one-time advance under the discretionary Working Capital Credit Facility with Hazel Partners Holdings LLC, to be used primarily for operating expenses. The company stresses this advance is a standalone accommodation that does not reinstate or reopen availability, creates no commitment for future funding, and provides no ongoing liquidity, and states it has no reasonable basis to expect further advances under the facility.
MSP Recovery, Inc. filed a prospectus supplement covering the resale of up to 56,896 shares of Class A common stock by selling securityholders. The shares include stock issued or issuable to Virage-affiliated entities under prior agreements and 11,180 shares issued to Palantir Technologies as compensation for products and services. Warrants tied to part of these shares have a low $0.0175 per share exercise price, so any cash the company receives from exercises would be only nominal.
Attached to the supplement, MSP Recovery reported a new letter agreement with Hazel Partners Holdings under its existing working capital credit facility. Hazel funded a one-time $250,000 advance on January 26, 2026 to be used primarily for operating expenses, increasing the Operational Collection Floor beyond its prior level. The company emphasizes this is a standalone accommodation, does not restore ongoing availability, and that it has no rights to, and no reasonable basis to expect, further advances or committed liquidity under this facility.
MSP Recovery, Inc. has filed a prospectus supplement covering the resale, from time to time, of up to 32,220 shares of Class A Common Stock by existing holders, including 15,239 shares issuable upon exercise of a CPIA Warrant at $0.4375 per share, which would generate only nominal proceeds if exercised.
The supplement also incorporates a new agreement under which Hazel Partners Holdings LLC provided a one-time $250,000 advance under the company’s discretionary working capital credit facility, primarily for operating expenses. The company emphasizes this is a standalone accommodation, does not restore ongoing borrowing capacity, and that it has no rights to and no reasonable basis to expect further advances under the facility.
MSP Recovery, Inc. filed a prospectus supplement registering up to 285,715 shares of Class A common stock for resale by Yorkville under an existing standby equity purchase agreement. The company will not receive proceeds from Yorkville’s resale of these shares, though it may receive cash when it elects to sell stock to Yorkville under the facility.
The attached current report also discloses a $250,000 one-time advance under MSP Recovery’s working capital credit facility with Hazel Partners Holdings. This advance is fully discretionary, does not reinstate borrowing capacity, and the company states it has no rights to and no reasonable basis to expect further funding under that facility, highlighting continued liquidity pressure alongside prior Nasdaq delisting and OTCQB trading.
MSP Recovery, Inc. filed a prospectus supplement covering up to 285,715 shares of Class A common stock that it may issue and sell to YA II PN, Ltd. (Yorkville) under a standby equity purchase agreement, with Yorkville then eligible to resell those shares from time to time. The Yorkville facility permits equity sales at discounts to market VWAP, subject to a 9.99% ownership cap, while prior stockholder approval has lifted an earlier exchange cap on issuance limits.
The supplement also includes a current report describing a new letter agreement under which Hazel Partners Holdings LLC, the lender under MSP Recovery’s working capital credit facility, made a one-time discretionary advance of $300,000 for operating expenses. The company states this advance does not reinstate or reopen ongoing borrowing capacity, emphasizes that the facility remains fully discretionary with no committed liquidity or borrowing base, and notes it has no rights to, or reasonable basis to expect, further advances from Hazel.
MSP Recovery, Inc. files a prospectus supplement covering the resale of up to 909,982 shares of Class A common stock and up to 755,200,000 warrants, plus the issuance of up to 236,019 shares upon warrant exercise. The Public Warrants have a reduced exercise price of $0.4375 per share, while the New Warrants carry a much higher $50,312.50 per share exercise price, which the company states makes exercises unlikely at recent market prices, and it does not expect to rely on New Warrant exercises for cash. As context, on January 21, 2026, the stock closed at $0.067 per share following a 1-for-7 reverse split. Separately, the company discloses a one-time $300,000 advance under its working capital facility with Hazel Partners Holdings LLC, solely for operating expenses, and emphasizes that this is a standalone accommodation with no commitment or reasonable basis to expect further funding.
MSP Recovery, Inc. has filed a prospectus supplement covering the resale of up to 56,896 shares of Class A common stock by selling securityholders. These include shares and warrants held by Virage Recovery Master LP, Virage Recovery Participation LP, and Palantir Technologies, Inc., with certain shares issuable upon exercise of warrants at an exercise price of $0.0175 per share, which would yield only nominal proceeds to the company if exercised.
The supplement also attaches a current report describing a new letter agreement with Hazel Partners Holdings LLC, under which Hazel made a one-time $300,000 advance under the existing working capital credit facility to be used solely for operating expenses. The company states this advance is a standalone accommodation, does not restore or expand ongoing availability under the facility, and that it has no rights to, and no reasonable basis to expect, any further advances.
MSP Recovery, Inc. filed a prospectus supplement covering the potential resale, from time to time, of up to 32,220 shares of its Class A common stock by selling securityholders, including up to 15,239 shares issuable upon exercise of the CPIA Warrant at an exercise price of $0.4375 per share. Any proceeds from sales will go to the selling securityholders, while the company would receive only nominal cash if the CPIA Warrant is exercised.
The company also disclosed that Hazel Partners Holdings LLC agreed to make a one-time $300,000 advance under its discretionary working capital credit facility to be used solely for operating expenses. This advance, funded on January 20, 2026, is described as a standalone accommodation that does not restore or expand ongoing borrowing availability and does not create any commitment for future funding.
MSP Recovery, Inc. has filed a prospectus supplement covering the resale of up to 56,896 shares of Class A common stock by existing holders. The shares include stock already issued to Virage-affiliated entities and Palantir Technologies, plus shares issuable upon exercise of low-priced warrants at $0.0175 per share, from which the company would receive only nominal proceeds.
The attached current report explains that a Nasdaq Hearings Panel has denied the company’s appeal of prior staff determinations, and the company’s common stock will be delisted from Nasdaq for failing to meet minimum stockholders’ equity of $2.5 million and a $1.00 bid price. Trading of the common stock is expected to continue on the OTCQB market under the ticker “MSPR.” The company also notes a 1-for-7 reverse stock split effective September 1, 2025, and all share figures reflect this split.
MSP Recovery, Inc. has registered for resale up to 32,220 shares of Class A common stock held by existing investors, including 15,239 shares issuable upon exercise of a CPIA Warrant with a per-share exercise price of $0.4375, from which the company would receive only nominal cash proceeds.
The prospectus supplement also incorporates a new report that the company’s common stock will be delisted from Nasdaq after it failed to meet the minimum stockholders’ equity requirement of $2.5 million and the minimum $1.00 bid price rule. Trading is expected to shift to the OTCQB market under the same “MSPR” ticker. A 1-for-7 reverse stock split effective September 1, 2025 is reflected in all share data.
MSP Recovery, Inc. updates its shelf prospectus to cover the resale by existing holders of up to 909,982 shares of Class A common stock, 755,200,000 warrants, and the potential issuance of up to 236,019 additional shares upon warrant exercise. The filing explains that Public Warrants, exercisable at $0.4375 per share, would generate less than $500 if fully exercised, while over 1.0 billion New Warrants carry a $50,312.50 per share exercise price and would not provide retained proceeds to the company, so operations are expected to rely on other cash sources. The company also notes a prior 1-for-7 reverse stock split effective September 1, 2025. In the attached current report, MSP Recovery discloses that a Nasdaq Hearings Panel has denied its appeal, and the company’s common stock will be delisted from Nasdaq for not meeting minimum stockholders’ equity of $2.5 million and the $1.00 minimum bid price, with trading expected to continue on the OTCQB market under the symbol “MSPR.”
MSP Recovery, Inc. is updating a resale registration covering up to 909,982 shares of Class A common stock, related warrants, and up to 236,019 shares issuable upon warrant exercise. These securities may be sold from time to time by existing holders; the company itself would receive only nominal cash (less than $500) from Public Warrant exercises and no cash from New Warrant exercises. A 1-for-7 reverse stock split took effect on September 1, 2025, and all share figures reflect this change.
The attached quarterly report shows very limited liquidity and heavy losses. As of September 30, 2025, MSP Recovery held cash of $1.8 million against total liabilities of $2.40 billion and reported a stockholders’ deficit of $563.8 million. For the first nine months of 2025, revenue was $1.6 million and the net loss was $723.3 million, driven largely by claims amortization and interest expense.
The company discloses “substantial doubt” about its ability to continue as a going concern and notes dependence on the Yorkville standby equity facility and a fully drawn Hazel working capital facility. It warns that, without new funding, it may need to pursue insolvency or U.S. bankruptcy protection. Nasdaq has issued a delisting determination for failing the minimum equity requirement, and MSP Recovery is appealing at a hearing scheduled for December 11, 2025; if unsuccessful, the stock is expected to move to the OTCQB market.
MSP Recovery, Inc. filed a prospectus supplement covering the resale of up to 32,220 shares of Class A common stock by existing holders, including 15,239 shares issuable upon exercise of the low-priced CPIA warrant at $0.4375 per share, from which the company would receive only nominal proceeds. The supplement incorporates the company’s Q3 2025 results.
For the quarter ended September 30, 2025, MSP Recovery generated $0.2 million in revenue and recorded a net loss of $245.5 million, contributing to a nine‑month net loss of $723.3 million. As of September 30, 2025, the company reported cash of about $1.8 million, total assets of $1.55 billion, total liabilities of $2.40 billion, and a stockholders’ deficit of $563.8 million, with total equity of $(844.4) million. Management states there is substantial doubt about its ability to continue as a going concern, given heavy dependence on Yorkville financing and constrained access to other funding.
The company executed a 1‑for‑7 reverse stock split effective September 1, 2025 and faces listing pressure. Nasdaq has issued a delisting determination for failure to meet the minimum equity requirement, and MSP Recovery has requested a hearing scheduled for December 11, 2025. If it cannot maintain its Nasdaq listing, it expects its shares to trade on the OTCQB market.
MSP Recovery, Inc. (MSPR) has filed a prospectus supplement registering the resale of up to 56,896 shares of Class A common stock held by existing investors, including shares issuable upon low-priced VRM and VRP warrants, from which the company would receive only nominal cash if exercised. The supplement attaches the latest quarterly report, which shows severe financial stress, including an operating loss of $375.5 million and a net loss of $723.3 million for the nine months ended September 30, 2025.
As of that date, MSP Recovery had $1.8 million of cash, a stockholders’ deficit of $563.8 million, and total liabilities of $2.4 billion, along with a large guaranty obligation tied to its Virage financing. Management discloses “substantial doubt” about the company’s ability to continue as a going concern, noting dependence on the Yorkville standby equity facility and fully drawn Hazel credit lines, and warning that failure to secure funding could lead to insolvency or bankruptcy proceedings. The company has also received a Nasdaq delisting determination over minimum equity requirements and plans to argue for continued listing, while shares may move to the OTCQB if delisted.
MSP Recovery, Inc. is registering up to 285,715 shares of Class A common stock for resale by Yorkville under a standby equity purchase agreement. The company may sell shares to Yorkville under this facility, but will not receive proceeds from Yorkville’s resales.
The Yorkville SEPA allows MSP Recovery to sell up to $250 million of stock, supported by multiple Yorkville convertible notes with principal commitments exceeding $18 million. MSP Recovery relies on this arrangement as its primary near‑term funding source. As of September 30, 2025, it held only $1.8 million in cash and reported a nine‑month net loss of $723.3 million, driven largely by claims amortization and $374.0 million of interest expense.
Stockholders’ equity was a deficit of $563.8 million, and management states there is substantial doubt about the company’s ability to continue as a going concern absent additional capital or much higher revenue. MSP Recovery has also received a Nasdaq delisting determination due to failing the minimum equity listing standard and has requested a hearing to seek continued listing.
MSP Recovery (MSPR) filed Prospectus Supplement No. 51 registering for resale up to 909,982 shares of Class A common stock, the resale of up to 755,200,000 warrants, and the potential issuance of up to 236,019 shares upon warrant exercise, after effectiveness and subject to terms described. The company expects only nominal proceeds from Public Warrant exercises and states it will not retain any proceeds from exercises of the New Warrants.
The supplement attaches a Current Report that updates financing and listing developments. The Floor Price under the Yorkville standby equity facility and related convertible notes was reduced to $0.50. Yorkville advanced a $0.50 million convertible note (net proceeds $0.45 million) with a conversion price based on 95% of the lowest five-day VWAP, not below the $0.50 floor, and subject to a 9.99% ownership cap. The Nomura promissory note was amended to reflect approximately $35.4 million principal and to permit up to $3.0 million of Yorkville convertible-note proceeds to fund operations. Nasdaq issued a delisting determination with trading suspension set for October 31, 2025; MSPR will request a panel review.
MSP Recovery, Inc. filed Prospectus Supplement No. 44 for the resale of up to 32,220 shares of Class A Common Stock by selling securityholders, including up to 15,239 shares issuable upon exercise of the CPIA Warrant at an exercise price of $0.4375 per share. The company will not receive proceeds from sales by the selling holders; it would receive only nominal proceeds if the CPIA Warrant is exercised.
The supplement attaches a Current Report on Form 8-K. The company and Yorkville reduced the SEPA floor price from $1.00 to $0.50 and Yorkville advanced a $0.50 million convertible note on October 28, 2025, resulting in net proceeds of $0.45 million. Convertible notes may convert at the lower of a fixed price or 95% of the lowest daily VWAP over five days, not below the $0.50 floor, subject to a 9.99% ownership cap. The Nomura note was amended to reflect approximately $35.4 million principal and to allow up to $3.0 million of SEPA proceeds to fund operations. Nasdaq issued a delisting determination on October 22, 2025; the company intends to request a panel review.
MSP Recovery (MSPR) filed Prospectus Supplement No. 33 covering the resale of up to 56,896 shares of Class A common stock by selling securityholders. The shares include up to 28,572 issuable upon exercise of VRM warrants, 2,858 issued to VRP and up to 14,286 issuable upon exercise of a VRP warrant, and 11,180 issued to Palantir. With a warrant exercise price of $0.0175 per share, the company would receive only nominal proceeds upon any warrant exercises; it would not receive proceeds from selling stockholder resales.
The attached update discloses a reduction of the Yorkville SEPA Floor Price from $1.00 to $0.50, and an additional Convertible Promissory Note advance of $0.50 million, yielding $0.45 million in net proceeds, with conversion at the lower of the fixed price or 95% of the 5‑day low VWAP, but not below $0.50, subject to a 9.99% ownership cap. The Nomura note was amended to reflect about $35.4 million principal and a limited waiver allowing up to $3.0 million of Yorkville convertible proceeds to fund operations. Nasdaq issued a delisting determination with trading suspension set for October 31, 2025, which the company plans to appeal. A 1‑for‑7 reverse split was effective September 1, 2025.
MSP Recovery, Inc. filed Prospectus Supplement No. 46 registering up to 285,715 shares of Class A common stock for potential resale by YA II PN, Ltd. (Yorkville) under its S-1. Sales by the selling stockholder will not deliver cash to the company, while MSP Recovery may receive proceeds from any shares it elects to sell to Yorkville under the Standby Equity Purchase Agreement.
The attached update notes a reduction of the Yorkville Floor Price from $1.00 to $0.50 and a new Convertible Promissory Note advance of $0.50 million, yielding net proceeds of $0.45 million. Nasdaq issued a Staff Delisting Determination to suspend trading on October 31, 2025; the company plans to request a hearing, and its shares may trade on the OTCQB Venture Market if delisted. A 1-for-7 reverse stock split took effect on September 1, 2025.